Medicare AdvantageCoverageHigh impact
Cough and Cold Medications (Revised)
Humana·Pulmonology, Oncology, Internal Medicine +3 more·Medicare Advantage
Effective date
Jan 1, 2006
We identified it
Jun 25, 2026
Summary
Humana's revised Cough and Cold Medications policy (effective January 1, 2006, revised August 27, 2025) clarifies that cough and cold medications are covered under Medicare Advantage Part D ONLY when used to treat an underlying medical condition causing cough (e.g., bronchodilators for asthma/COPD bronchospasm, cough from lung cancer), NOT for symptomatic relief. Claims for symptomatic cough/cold treatment will be denied as excluded drugs. Billing teams must verify medical necessity and route requests through non-formulary exceptions process.
Action Required
IMMEDIATELY: Billing team must implement the following: (1) Review all pending and recent cough and cold medication claims to identify any submitted for symptomatic relief only—these must be corrected or recalled as they are now excluded from Part D coverage. (2) Update internal billing guidelines and claim submission procedures to require documentation of the UNDERLYING MEDICAL CONDITION (e.g., asthma, COPD, lung cancer, severe osteoporosis) that is causing the cough, not just the cough symptom itself. (3) Instruct providers to document clinical justification linking the medication to the underlying condition, not symptomatic treatment. (4) Route all cough and cold medication requests through Humana's non-formulary exceptions process per policy guidance—do NOT bill standard claims. (5) Train front-desk and billing staff to flag cough and cold medication prescriptions for clinical review BEFORE claim submission to prevent denials. Failure to comply will result in claim denials and potential overpayment recovery for any claims submitted without proper medical necessity documentation tied to an underlying condition.